Eberlin Alexander Redvers,Del Rio Gancedo Susana,Hague Andrew B.,Renou Ludovic Sylvain Marc,Grenier Louis,Genov Daniel G.
申请号:
NZ62903714
公开号:
NZ629037A
申请日:
2014.03.13
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
Disclosed are solid crystalline forms of a compound of formula (I), their a salts, solvates, and solvates of their salts. The compound is suitable to modulate kinase activity, including PI3 kinase activity. Also disclosed are processes for preparing solid forms of the compound of formula (I) and their salts, and pharmaceutical compositions thereof. The compound of formula (I) is (S)-2-amino-4-((1-(8-(2-methoxypyridin-4-yl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)amino)pyrimidine-5-carbonitrile.